Is Hemopexin a Nephrotoxin or a Marker of Kidney Injury in Renal Ischemia-Reperfusion?
- PMID: 39766229
- PMCID: PMC11673696
- DOI: 10.3390/biom14121522
Is Hemopexin a Nephrotoxin or a Marker of Kidney Injury in Renal Ischemia-Reperfusion?
Abstract
Destabilization of heme proteins is recognized to play a role in acute kidney injury (AKI). Hemopexin (Hpx), known for its role in binding heme, mitigates free heme toxicity. Despite this, the potential adverse effects of Hpx deposition in kidney tissues and its impact on kidney function are not fully understood. Deferoxamine (DFO) chelates iron released from heme and mitigates associated kidney damage. Therefore, this study aimed to evaluate whether Hpx contributes to kidney injury in an ischemia-reperfusion injury (IRI) induced AKI model and to investigate if DFO could alleviate this damage. Mice were categorized into five groups: Sham-Vehicle, Sham-Hpx, IRI-Vehicle, IRI-Hpx, and IRI-Hpx-DFO. Decline in kidney function was observed exclusively in the IRI group, independent of Hpx injection. Serum Hpx levels remained comparable across all groups, and administration of Hpx did not alter serum Hpx levels or kidney function after 24 hours. Although increased Hpx deposition in kidneys was noted in both the IRI and Hpx groups, this accumulation did not correlate with impaired kidney function. Additionally, DFO did not exhibit a protective effect against kidney injury. In summary, Hpx does not directly induce kidney injury and cannot be considered a biomarker for kidney damage caused by IRI.
Keywords: acute kidney injury; biomarker; hemopexin; ischemia-reperfusion injury.
Conflict of interest statement
The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures





Similar articles
-
Renal cortical hemopexin accumulation in response to acute kidney injury.Am J Physiol Renal Physiol. 2012 Nov 15;303(10):F1460-72. doi: 10.1152/ajprenal.00426.2012. Epub 2012 Sep 19. Am J Physiol Renal Physiol. 2012. PMID: 22993068 Free PMC article.
-
Hemopexin promotes angiogenesis via up-regulating HO-1 in rats after cerebral ischemia-reperfusion injury.BMC Anesthesiol. 2018 Jan 3;18(1):2. doi: 10.1186/s12871-017-0466-4. BMC Anesthesiol. 2018. PMID: 29298658 Free PMC article.
-
Hemopexin alleviates cognitive dysfunction after focal cerebral ischemia-reperfusion injury in rats.BMC Anesthesiol. 2019 Jan 15;19(1):13. doi: 10.1186/s12871-019-0681-2. BMC Anesthesiol. 2019. PMID: 30646866 Free PMC article.
-
Hemopexin accumulates in kidneys and worsens acute kidney injury by causing hemoglobin deposition and exacerbation of iron toxicity in proximal tubules.Kidney Int. 2022 Dec;102(6):1320-1330. doi: 10.1016/j.kint.2022.07.024. Epub 2022 Aug 23. Kidney Int. 2022. PMID: 36007598
-
Heat-shock proteins and acute ischaemic kidney injury.Nephron Exp Nephrol. 2014;126(4):167-74. doi: 10.1159/000363323. Epub 2014 Jun 6. Nephron Exp Nephrol. 2014. PMID: 24923736 Review.
References
-
- Liu K.D., Goldstein S.L., Vijayan A., Parikh C.R., Kashani K., Okusa M.D., Agarwal A., Cerda J., AKI!Now Initiative of the American Society of Nephrology AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI. Clin. J. Am. Soc. Nephrol. 2020;15:1838–1847. doi: 10.2215/CJN.15611219. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous